AR and neoplasm: AR-tropomyosin receptor kinase (TRK) crosstalk mediated through nerve growth factor (NGF) also promoted tumor growth in ARSI challenged PCa cell lines, and are targetable by NTRK1/TRKA inhibitors [125].